Similar articles

• Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.

  Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, Klepetko W. Zuckermann A, et al. J Thorac Cardiovasc Surg. 2003 Apr;125(4):891-900. doi: 10.1067/mtc.2003.71. J Thorac Cardiovasc Surg. 2003. PMID: 12698153 Clinical Trial.
• Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.

  Busque S, Shoker A, Landsberg D, McAlister V, Halloran P, Shapiro J, Peets J, Schulz M. Busque S, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1266-7. doi: 10.1016/s0041-1345(00)02471-4. Transplant Proc. 2001. PMID: 11267285 Clinical Trial. No abstract available.
• Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.

  Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA. Bakr MA, et al. Exp Clin Transplant. 2008 Mar;6(1):48-53. Exp Clin Transplant. 2008. PMID: 18405245 Clinical Trial.
• [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].

  Uchida K. Uchida K. Nihon Jinzo Gakkai Shi. 2005;47(4):423-9. Nihon Jinzo Gakkai Shi. 2005. PMID: 15971884 Review. Japanese. No abstract available.
• New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.

  Hunt SA. Hunt SA. Cardiol Rev. 2000 May-Jun;8(3):180-4. Cardiol Rev. 2000. PMID: 11174892 Review.